Financial Daily from THE HINDU group of publications
Tuesday, Feb 15, 2005

News
Features
Stocks
Port Info
Archives
Google

Group Sites

Corporate - Economic Offences


Serious fraud office moves court against Daewoo Motors India

Richa Mishra

New Delhi , Feb. 14

THE Serious Fraud Investigation Office (SFIO) has filed almost 16 cases against Daewoo Motors India Ltd (DMIL) before the designated court that considers company cases.

With this, the SFIO proposes to bring its investigations to an end. According to official sources, some of the issues on which the cases have been filed include siphoning of funds to related companies, transfer of funds to parent company, Daewoo Corporation of Korea, and over-invoicing.

The case has been filed at the designated courts in Delhi. The SFIO had sought the Ministry of Company Affairs' permission to initiate prosecution against the company.

It has approached the Ministry for appointing one of its officers as a company prosecutor to take up company cases, the sources said.

A high-power team of the Ministry, which was set up to examine the investigation report of the SFIO on the company, has suggested initiating prosecution against DMIL after following the due process of law. The team in its report endorsed SFIO's recommendations for initiating prosecution against the company for non-maintenance of records and disposal of assets without shareholders' approval.

Further, it has recommended that the company and its officers in default should be punished under the Indian Penal Code for falsification of accounts and records for the withdrawal of working capital. Further, the team has also pointed out the violation of conditions imposed by the Union Government on inter-corporate deposits.

According to Ministry sources, the committee has suggested a probe on issues such as over-invoicing of capital goods imports, investment in shares and securities and the role of auditors.

Design Auto, Bonanza Biotech reports submitted

The SFIO has submitted its report on Madhya Pradesh-based Design Auto Systems Ltd and Bonanza Biotech, the two companies accused of manipulating share prices, to the Ministry of Company Affairs. Official sources told Business Line that the investigations have revealed that the two entities indulged in price manipulation.

Both were allegedly involved in fraudulently issuing shares worth Rs 100 crore to each other in 2002. The cases were referred to SFIO in December 2003.

However, the Indore Bench of the Madhya Pradesh High Court in the matter of Design Auto had granted an interim stay in January 2004, which had resulted in delays in proceedings for both the cases, as they were interlinked, the sources said.

Once the stay was vacated, the investigations were carried forward. Besides, no specific time limit was prescribed for completing the investigations.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page


Stories in this Section
Dabur appoints Narang on Balsara boards; may buy out residual stake


REL to introduce remote meter reading system
Reliance Ind to supply ATF, gas oil to Ceylon Petro
Wockhardt hopes for Rs 100-cr sales in biotech products
Mahindra launches Australian operations
Reliance Infocomm denies charges of `Mahajan link'
NHPC's Dhauliganga project to go on stream in March
Sujana Ind supplies components to Tecumseh arm
Kishore Chhabria transfers stake in Herbertsons to escrow agent — Wants amicable out-of-court deal for Rs 131 cr
BHEL bags safety initiative award
GAIL signs deal for 10 pc stake in China Gas
`Proper training for independent directors must'
AVT to go global with marigold unit in China
Glaxo plans facility at Nashik to make vaccines
De-fluoridation project in Nalgonda dist.
Eastern Condiments sets up hi-tech lab for testing spices
Serious fraud office moves court against Daewoo Motors India


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line